Lumax DX / Linox DX Evaluation

Evaluation of the Lumax DX ICD and the Linox DX Lead (ICD=Implantable Cardioverter Defibrillator, DX=Extended Diagnostics)

The objective of this study is to investigate the safety and efficacy of the Lumax DX / Linox DX system.

No hypothesis has been defined.

Inclusion Criteria:

• Patient meets the indication for ICD therapy
• LVEF ≥ 30%
• Patient's compliance with protocol
• Signed patient informed consent form

Exclusion Criteria:

• Patient meets one contraindication for ICD therapy
• Permanent atrial tachyarrhythmia
• Age < 18 years
• Cardiac surgery planned within the next 6 months
• Life expectancy of less than 6 months
• Limited contractual capability
• Participating in another clinical study of an investigational cardiac drug or device